Steven Cohen Spring Works Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,489,814 shares of SWTX stock, worth $56.1 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
1,489,814
Previous 2,162,176
31.1%
Holding current value
$56.1 Million
Previous $78.9 Million
7.08%
% of portfolio
0.19%
Previous 0.2%
Shares
9 transactions
Others Institutions Holding SWTX
# of Institutions
234Shares Held
67.7MCall Options Held
546KPut Options Held
29.4K-
Vanguard Group Inc Valley Forge, PA6.53MShares$246 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.44MShares$205 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.11MShares$155 Million0.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.48MShares$131 Million5.66% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$129 Million8.76% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.35B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...